Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Heart (British Cardiac Society)|June 23, 2026
Cardiac and extracardiac outcomes after heart transplantation in laminopathiesGauthier Giordano, Guillaume Coutance, Karim Wahbi, et al.
Radiology|August 17, 2017
Cardiac MR Strain: A Noninvasive Biomarker of Fibrofatty Remodeling of the Left Atrial MyocardiumAdrian T Huber, Jérôme Lamy, Amer Rahhal, et al.
European Heart Journal|May 12, 2009
A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathyFelix W Friedrich, Pedro Bausero, Yuli Sun, et al.
Heart (British Cardiac Society)|July 28, 2019
Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathyCéline Bégué, Stellan Mörner, Dulce Brito, et al.
Human Molecular Genetics|November 19, 2004
Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathiesTakuro Arimura, Anne Helbling-Leclerc, Catherine Massart, et al.
Blood|August 30, 2003
Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate modelFrançoise Norol, Pascal Merlet, Richard Isnard, et al.
Journal of the American College of Cardiology|April 11, 2020
Antithrombotic Therapy for Patients With Left Ventricular Mural ThrombusBenoit Lattuca, Nesrine Bouziri, Mathieu Kerneis, et al.
International Journal of Cardiology. Heart & Vasculature|November 28, 2025
Prognostic impact of the number and Temporality of heart failure Hospitalisations: Analysis of a National healthcare databaseDamien Logeart, François Roubille, Muriel Salvat, et al.
European Journal of Heart Failure|November 16, 2012
A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activityFelix W Friedrich, Gilles Dilanian, Patricia Khattar, et al.
Pageof 10